Setting new standards in information exchange for the pharmaceutical and biotech industry
IO360° Co-hosts KOL Breakfast with Dr Carl June at J.P. Morgan 2018
January 8, 2018
IO360° is delighted to co-host with the Trout Group a KOL breakfast with immunotherapy pioneer, Dr Carl June of The University of Pennsylvania, taking place during the 36th Annual J.P. Morgan Healthcare Conference in San Francisco.
Dr June will deliver a keynote on the CAR-T landscape and technology that is in near-term translation.
Dr June most recently led the development of an experimental therapy for advanced childhood leukemia that become the first CAR T-cell therapy, known as Novartis’ Kymriah, to win FDA approval in August 2017.
For more information on the KOL Breakfast with Dr Carl June, contact Thomas Hoffmann at the Trout Group, Thoffmann@troutgroup.com.
Learn more about IO360°.